Submission of revised intimation of appointment of Chief Financial Officer.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Novelix Pharmaceuticals Ltd has submitted a revised intimation to BSE regarding the appointment of Mrs. Bhoomika Choudhary as the Chief Financial Officer of the company. The appointment was approved by the Board of Directors at a meeting held on February 12, 2025, and is effective from the same date. Mrs. Choudhary is a Post Graduate in Commerce from Rajasthan University, Jaipur, with over three years of experience in accounting and finance. She is not related to any existing Directors, Key Managerial Personnel, or Promoters of the company. This filing is a corrected resubmission of an earlier disclosure dated February 12, 2025.
This is a routine corporate governance update confirming a CFO appointment. It has no direct material impact on shareholders or the stock price, though it brings the company's compliance disclosures up to date.